SR1555 is a selective retinoic acid receptor-related orphan receptor gamma (RORγ) inverse agonist with an IC50 of 1 μM; it can be used in the research of autoimmune diseases by inhibiting the development and function of TH17 cells, enhancing the generation of regulatory T cells, and suppressing IL-17 expression.